Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in inflammatory bowel disease.

B R Stotland1, R B Stein, G R Lichtenstein

  • 1Department of Medicine, Boston Medical Center, Boston University Medical School, Massachusetts, USA.

The Medical Clinics of North America
|October 12, 2000
PubMed
Summary

Optimal management of Inflammatory Bowel Disease (IBD) involves a team approach and evolving therapies. Advancements in biologics and surgical techniques significantly improve patient quality of life and outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.

The American journal of gastroenterology·2020
Same author

Intraspinal microstimulation produces over-ground walking in anesthetized cats.

Journal of neural engineering·2016
Same author

Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study.

Alimentary pharmacology & therapeutics·2014
Same author

Real-time control of walking using recordings from dorsal root ganglia.

Journal of neural engineering·2013
Same author

Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells.

Inflammatory bowel diseases·2013
Same author

Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.

Alimentary pharmacology & therapeutics·2012

Area of Science:

  • Gastroenterology and Internal Medicine
  • Surgical Innovation

Background:

  • Inflammatory Bowel Disease (IBD) management necessitates a comprehensive, multidisciplinary strategy.
  • The evolving landscape of IBD treatment offers improved quality of life for chronic disease patients.

Purpose of the Study:

  • To summarize recent advancements in the medical and surgical management of Inflammatory Bowel Disease.
  • To highlight the importance of staying current with peer-reviewed literature for optimal patient care.

Main Methods:

  • Review of current literature on Inflammatory Bowel Disease therapies.
  • Analysis of advancements in biologic agents and surgical procedures.

Main Results:

  • Biologic agents are expanding therapeutic options, potentially complicating treatment algorithms.

Related Experiment Videos

  • Surgical innovations like ileoanal anastomosis and strictureplasty have dramatically improved outcomes.

    • Conclusions:

    • Optimal IBD management requires a coordinated multidisciplinary team.
    • Continuous attention to new therapies and refined treatments is crucial for clinicians treating IBD patients.